comparemela.com
  1. Home
  2. Live Updates
  3. Dragonfly Therapeutics Inc - Breaking News

Dragonfly Therapeutics Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Collab to drive development of solid tumour combination therapy

The EGFR immune engager in combination with pembrolizumab is expected to be administered to the first patients in late 2024.

Therapeutics incDragonfly therapeutics incDragonfly therapeuticsBill haney

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.